Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Interest Expenses (2024)

Historic Interest Expenses for Kairos Pharma (KAPA) over the last 1 years, with Q4 2024 value amounting to $133000.0.

  • Kairos Pharma's Interest Expenses changed N/A to $133000.0 in Q4 2024 from the same period last year, while for Jun 2025 it was $670000.0, marking a year-over-year change of. This contributed to the annual value of $670000.0 for FY2024, which is 149523.81% up from last year.
  • Latest data reveals that Kairos Pharma reported Interest Expenses of $133000.0 as of Q4 2024.
  • In the past 5 years, Kairos Pharma's Interest Expenses registered a high of $537000.0 during Q3 2024, and its lowest value of $12000.0 during Q2 2024.